SIT Acquires SULMETIN Fom Sanofi

Portada de un comunicado de prensa del grupo SIT, en la que aparecen los logotipos de SIT Laboratorio Farmacéutico y Desma, con la leyenda en el centro: SIT Press Release

SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.